ClinicalTrialsFinder

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Clinical Trials in Cleveland, Ohio

1 recruitingCleveland, Ohio

Showing 1–1 of 1 trials

Recruiting
Phase 3

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Stage IIIB Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Advanced Lung Non-Squamous Non-Small Cell Carcinoma+2 more
National Cancer Institute (NCI)300 enrolled604 locationsNCT04181060